Toronto Dominion Bank’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.62M Sell
42,851
-5,908
-12% -$1.47M 0.01% 639
2025
Q4
$11.7M Sell
48,759
-5,598
-10% -$1.43M 0.02% 586
2025
Q3
$14.9M Sell
54,357
-5,186
-9% -$1.42M 0.02% 511
2025
Q2
$15.4M Buy
59,543
+8,035
+16% +$1.92M 0.03% 454
2025
Q1
$11.5M Buy
51,508
+159
+0.3% +$37.1K 0.02% 458
2024
Q4
$11.7M Buy
51,349
+2,099
+4% +$505K 0.02% 486
2024
Q3
$12M Buy
49,250
+6,476
+15% +$1.45M 0.02% 422
2024
Q2
$8.19M Sell
42,774
-1,031
-2% -$209K 0.01% 540
2024
Q1
$8.67M Sell
43,805
-39,860
-48% -$7.3M 0.01% 522
2023
Q4
$14.4M Buy
83,665
+6,777
+9% +$1.04M 0.02% 460
2023
Q3
$11.4M Sell
76,888
-2,728
-3% -$493K 0.02% 469
2023
Q2
$17.4M Buy
79,616
+2,267
+3% +$505K 0.03% 402
2023
Q1
$16.9M Buy
77,349
+180
+0.2% +$39.1K 0.03% 367
2022
Q4
$16.1M Buy
77,169
+12,595
+20% +$2.77M 0.02% 388
2022
Q3
$14.1M Sell
64,574
-10,607
-14% -$2.41M 0.03% 389
2022
Q2
$15.8M Sell
75,181
-7,414
-9% -$1.58M 0.03% 308
2022
Q1
$20M Sell
82,595
-3,201
-4% -$774K 0.03% 293
2021
Q4
$22.3M Buy
85,796
+6,588
+8% +$1.71M 0.03% 318
2021
Q3
$20.9M Buy
79,208
+15,407
+24% +$4.21M 0.03% 287
2021
Q2
$15.7M Sell
63,801
-7,092
-10% -$1.49M 0.02% 365
2021
Q1
$13.8M Sell
70,893
-19,590
-22% -$3.93M 0.02% 356
2020
Q4
$19.2M Buy
90,483
+8,825
+11% +$1.76M 0.04% 290
2020
Q3
$14M Sell
81,658
-13,319
-14% -$2.46M 0.03% 304
2020
Q2
$18.2M Sell
94,977
-13,592
-13% -$2.22M 0.05% 270
2020
Q1
$16M Sell
108,569
-25,373
-19% -$4.04M 0.05% 254
2019
Q4
$20.8M Buy
133,942
+28,199
+27% +$4.06M 0.03% 299
2019
Q3
$14.3M Sell
105,743
-97,349
-48% -$12.8M 0.03% 365
2019
Q2
$12.4M Buy
203,092
+103,650
+104% +$11.5M 0.03% 403
2019
Q1
$10.3M Buy
99,442
+14,322
+17% +$1.48M 0.02% 482
2018
Q4
$9.69M Sell
85,120
-7,656
-8% -$820K 0.02% 417
2018
Q3
$10.7M Buy
92,776
+998
+1% +$109K 0.02% 442
2018
Q2
$9.5M Buy
91,778
+14,804
+19% +$1.5M 0.02% 476
2018
Q1
$7.58M Buy
76,974
+15,832
+26% +$1.5M 0.02% 496
2017
Q4
$5.18M Buy
61,142
+7,216
+13% +$596K 0.02% 522
2017
Q3
$4.15M Buy
53,926
+52,186
+2,999% +$3.99M 0.01% 513
2017
Q2
$135K Buy
1,740
+197
+13% +$14.1K ﹤0.01% 895
2017
Q1
$111K Buy
1,543
+324
+27% +$22.4K ﹤0.01% 917
2016
Q4
$76K Buy
1,219
+7
+0.6% +$429 ﹤0.01% 934
2016
Q3
$79K Buy
1,212
+442
+57% +$29.4K ﹤0.01% 951
2016
Q2
$49K Buy
770
+4
+0.5% +$236 ﹤0.01% 894
2016
Q1
$44K Buy
+766
New +$43.4K ﹤0.01% 944

Other funds holding RMD

Toronto Dominion Bank's RMD Position: Q1 2026 in Review

Toronto Dominion Bank reduced its ResMed (RMD) stake by 12% in Q1 2026, selling an estimated $1.47M and leaving 42,851 shares worth $9.62M. The position accounts for 0.01% of the portfolio, ranked #639.

Toronto Dominion Bank first reported a position in RMD in Q1 2016 and has held it in 41 quarters since. The position peaked at $22.3M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Toronto Dominion Bank held 42,851 shares of ResMed worth $9.62M as of Q1 2026.
  • Toronto Dominion Bank sold 5,908 ResMed shares in Q1 2026, an estimated $1.47M.
  • ResMed made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #639 holding.
  • Toronto Dominion Bank first reported a position in ResMed in Q1 2016 and has held it in 41 quarters since.
  • Toronto Dominion Bank's ResMed position peaked at $22.3M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.